Chemotherapy, Holmium Ho 166 DOTMP, and Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma

NCT00045136 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

INDUSTRY

Sponsor class

Conditions

Multiple Myeloma and Plasma Cell Neoplasm

Interventions

DRUG: melphalan
PROCEDURE: peripheral blood stem cell transplantation
RADIATION: holmium Ho 166 DOTMP

Sponsor

Poniard Pharmaceuticals